Search - tctmd.com

Displaying 121 - 135 of 135

Sort: Relevancy | Date

News Daily News

Subcutaneous ICD Has Favorable Outcomes in Older Patients

Todd Neale

March 15, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Female Cardiologists Still Face Pushback as Physician-Researchers

Caitlin E. Cox

February 28, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

ROOBY-FS: 10-Year Data Affirm On-Pump CABG as Default Strategy

L.A. McKeown

February 18, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Even Less-Severe COVID-19 Can Have Long-term CV Effects

Caitlin E. Cox

February 10, 2022

News Conference News ISC 2022

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

Todd Neale

February 10, 2022

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

Presentation THT 2022

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Presenter: Mohammed Al-Sadawi

February 01, 2022

News Daily News

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

Todd Neale

January 25, 2022

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Caitlin E. Cox

January 07, 2022

Presentation Controversies and Advances 2021

Device Detected Atrial Fibrillation: NOAC or Not?

Presenter: Roopinder K. Sandhu

December 03, 2021

Video

» Interview

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

April 3, 2022

Advertisement

Subcutaneous ICD Has Favorable Outcomes in Older Patients

Guideline-Directed Therapies Underused in Frail HF Patients

Female Cardiologists Still Face Pushback as Physician-Researchers

Fewer Diabetic Complications Seen When NOACs Given for AF

ROOBY-FS: 10-Year Data Affirm On-Pump CABG as Default Strategy

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Even Less-Severe COVID-19 Can Have Long-term CV Effects

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Device Detected Atrial Fibrillation: NOAC or Not?

ACC 2022: PACIFIC AF - Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with A-Fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content